HUP9904485A3 - Lowering blood levels of lipoprotein (a) - Google Patents
Lowering blood levels of lipoprotein (a)Info
- Publication number
- HUP9904485A3 HUP9904485A3 HU9904485A HUP9904485A HUP9904485A3 HU P9904485 A3 HUP9904485 A3 HU P9904485A3 HU 9904485 A HU9904485 A HU 9904485A HU P9904485 A HUP9904485 A HU P9904485A HU P9904485 A3 HUP9904485 A3 HU P9904485A3
- Authority
- HU
- Hungary
- Prior art keywords
- lipoprotein
- blood levels
- lowering blood
- lowering
- levels
- Prior art date
Links
- 102000057248 Lipoprotein(a) Human genes 0.000 title 1
- 108010033266 Lipoprotein(a) Proteins 0.000 title 1
- 230000036765 blood level Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11110098P | 1998-12-04 | 1998-12-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9904485D0 HU9904485D0 (en) | 2000-02-28 |
HUP9904485A2 HUP9904485A2 (en) | 2000-08-28 |
HUP9904485A3 true HUP9904485A3 (en) | 2000-09-28 |
Family
ID=22336605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9904485A HUP9904485A3 (en) | 1998-12-04 | 1999-12-03 | Lowering blood levels of lipoprotein (a) |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2000169395A (en) |
KR (1) | KR20000047857A (en) |
CA (1) | CA2291471A1 (en) |
HU (1) | HUP9904485A3 (en) |
IL (1) | IL133201A0 (en) |
ZA (1) | ZA997446B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324801A1 (en) * | 1999-11-10 | 2001-05-10 | Andrew Gordon Swick | Use of apo b secretion/mtp inhibitors and anti-obesity agents |
IL139450A0 (en) * | 1999-11-10 | 2001-11-25 | Pfizer Prod Inc | Methods of administering apo b-secretion/mtp inhibitors |
IL139449A0 (en) * | 1999-11-10 | 2001-11-25 | Pfizer Prod Inc | Use of apo b secretion/mtp inhibitors |
CA2324800A1 (en) * | 1999-11-10 | 2001-05-10 | Mary Anne Hickman | Use of apo b secretion/mtp inhibitors |
US7625948B2 (en) | 2002-02-28 | 2009-12-01 | Japan Tobacco Inc. | Ester compound and medicinal use thereof |
WO2005021486A1 (en) | 2003-08-29 | 2005-03-10 | Japan Tobacco Inc. | Ester derivative and medicinal use thereof |
JP5697296B2 (en) | 2004-03-05 | 2015-04-08 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Method for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia with minimal side effects |
US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
-
1999
- 1999-11-29 IL IL13320199A patent/IL133201A0/en unknown
- 1999-12-02 ZA ZA9907446A patent/ZA997446B/en unknown
- 1999-12-02 JP JP11342833A patent/JP2000169395A/en active Pending
- 1999-12-02 CA CA002291471A patent/CA2291471A1/en not_active Abandoned
- 1999-12-02 KR KR1019990054413A patent/KR20000047857A/en not_active Application Discontinuation
- 1999-12-03 HU HU9904485A patent/HUP9904485A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2291471A1 (en) | 2000-06-04 |
HUP9904485A2 (en) | 2000-08-28 |
HU9904485D0 (en) | 2000-02-28 |
ZA997446B (en) | 2001-06-04 |
IL133201A0 (en) | 2001-03-19 |
JP2000169395A (en) | 2000-06-20 |
KR20000047857A (en) | 2000-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103526A3 (en) | Catheter set | |
GB9703637D0 (en) | Surgical instrumentation | |
AU1450900A (en) | Methods of treatment of type 2 diabetes | |
AUPP713498A0 (en) | A method of detecting blood | |
GB9811116D0 (en) | Method of altering heartbeat | |
HU9904485D0 (en) | Lowering blood levels of lipoprotein (a) | |
GB9802517D0 (en) | Alterness monitor | |
EP1135119A4 (en) | Glucose and lipid lowering compounds | |
GB9916051D0 (en) | Insertable insole | |
GB9820804D0 (en) | ANSI syringe | |
PL332879A1 (en) | Method of obtaining biphenol a | |
GB9824518D0 (en) | Patient movement aid | |
GB0009679D0 (en) | Medical drainage apparatus | |
ZA991746B (en) | Managing use of a medical aid scheme | |
AU142197S (en) | Tissue | |
IL124294A0 (en) | Physiological monitoring of a subject | |
GB9812314D0 (en) | Treatment of diabetes | |
GB9815149D0 (en) | Treatment of diabetes | |
GB9917285D0 (en) | Medical apparatus | |
TW501487U (en) | Novel structure of goggles | |
PL326133A1 (en) | Method of obtaining biphenol a | |
TW344214U (en) | Improved structure of a fryer | |
TW409704U (en) | Structure of hermetic can | |
GB9817916D0 (en) | Arterial cannula | |
TW435201U (en) | Improved structure of stethoscope |